The Power To Alter Disease's Course
Product development entrepreneur with over 20 years experience founding technology startups. Jeff is an innovator who utilizes emerging technologies to start companies that creatively fill gaps in existing markets. He specializes in startup environments at the conception stage where ideas become products and teams are assembled to bring those products to market. Companies include CrowdOptic, LoanHounds (acquired by QuinStreet), StockPoint (acquired by Pinnacor)..
Dr. Lisk is board certified neurologist with a fellowship in movement disorders. He is involved in many ongoing national clinical research trials in Parkinson’s disease. Memberships include The American Academy of Neurology, Association of Ring Side Physicians, The Movement Disorder Society and a member of the medical advisory board for the California State Athletic Commission. Dr. Lisk has been on the board of directors of the American Heart Association African-American Task Force for the Western States, Alzheimer’s Association Board Member and received the 2010 NAACP Man of Valor Award.
Ken is an executive improving healthcare through the development of new products and services by integrating technology, big data, and advanced data analytics. Developed and launched first electronic home based motor test battery trial for Parkinson’s disease in partnership with Intel and scientists worldwide. University of California, Berkeley. Stanford University Graduate School of Business. Director of Data Science The Michael J. Fox Foundation for Parkinson's Research Managing Director Kinetics Foundation
John is an accomplished member of the pharmaceutical community and has held many leadership positions in many top 10 pharmaceutical organizations. His extensive experience in neurodegenerative diseases has helped many brands become leaders in their markets and help drive patient outcomes. The most rewarding aspect of his career is being able to enhance patients' lives living with Multiple Sclerosis, Parkinson's disease, and Huntington's disease. This passion for the patient has helped him receive many honors the APDA and the MS nursing society.
Board-certified toxicologist specializing in the nonclinical development of small and large molecule therapeutics. She has directed toxicology, pharmacokinetics, bioanalytical development and animal resources groups, lead project teams and subteams, and mentored many scientists. She has experience defending nonclinical development plans to US, EU and Japanese regulatory authorities. Sangamo BioSciences, BioMarin, XOMA, Elan Pharmaceuticals.
Clinician and medical device entrepreneur with experience in applying clinical and scientific knowledge to product development, intellectual property, regulatory issues, research and marketing. Sanovas, Inc., California Pacific Medical Center, Aardvark Medical, Rinotherm, NovaBay Pharmaceuticals.
Dr. Little is active with the Parkinson’s community, particularly in programs and studies related to exercise. She is the inspiration behind Beneufit and continues to inspire people today. She has climbed Mt Kilimanjaro, trekked to Annapurna Base Camp, the Inca Trail and finished the RAGBRAI bicycle ride across Iowa.